Israel: Fifth Subject Treated, One More Enrolled

On July 14, 2015, the fifth subject was treated in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. The seventh subject was enrolled on July 23. Led by Principal Investigator Moshe Kotler, …

Canada: Two More Subjects Treated

On June 26 and July 3, 2015, the fifth and sixth subjects were treated in our ongoing Canadian study of MDMA-assisted psychotherapy for PTSD. The sixth subject was enrolled on June 29. Led by Principal …

Israel: Two More Subjects Enrolled

On June 24 and 25, 2015, the fifth and sixth subjects were enrolled in our ongoing Israeli study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Moshe Kotler, M.D., this Phase 2 …

Boulder: 21st Subject Treated; Two More Enrolled

On June 19, 2015, the 21st subject was treated in our ongoing study of MDMA-assisted psychotherapy for subjects with PTSD from sexual assault, violent crime, war, natural disasters, or any other cause, …

Canada: Fifth Subject Enrolled

On June 10, 2015, the fifth subject was enrolled in our ongoing Canadian study of MDMA-assisted psychotherapy for PTSD. Led by Principal Investigator Ingrid Pacey, M.D., in Vancouver, B.C., this Phase …

Boulder: 19th Subject Treated

On April 24, 2015, the 19th subject was treated in our ongoing study of MDMA-assisted psychotherapy in 23 subjects with PTSD from sexual assault, violent crime, war, natural disasters, or any other cause, …

Boulder: 18th Subject Treated

On March 22, 2015, the 18th subject was treated in our ongoing study of MDMA-assisted psychotherapy for PTSD in 23 subjects with PTSD from sexual assault, violent crime, war, natural disasters, or any …

Canada: Third Subject Treated in Vancouver Study

On March 14, 2015, the third subject received their first experimental treatment in our Canadian study of MDMA-assisted psychotherapy for PTSD. The second subject received their first treatment on Feb …

Canada: First Subject Treated in Vancouver Study

On February 3, 2015, the first subject received their first experimental treatment in our Canadian study of MDMA-assisted psychotherapy for PTSD. The purpose of this small Phase 2 study in up to 12 subjects …